L Holmberg
Overview
Explore the profile of L Holmberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
379
Citations
4864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stromberg U, Bonander C, Westerberg M, Levin L, Metcalfe C, Steele R, et al.
EClinicalMedicine
. 2022 Apr;
47:101398.
PMID: 35480071
Background: We have addressed health equity attained by fecal immunochemical testing (FIT) and primary colonoscopy (PCOL), respectively, in the randomised controlled screening trial SCREESCO conducted in Sweden. Methods: We analysed...
2.
Wennstig A, Garmo H, Wadsten L, Lagerqvist B, Fredriksson I, Holmberg L, et al.
Strahlenther Onkol
. 2022 Apr;
198(7):630-638.
PMID: 35389076
Purpose: Adjuvant radiotherapy (RT) for breast cancer is associated with an increased risk of ischemic heart disease. We examined the risk of coronary artery stenosis in a large cohort of...
3.
Wulaningsih W, Garmo H, Ahlgren J, Holmberg L, Folkvaljon Y, Wigertz A, et al.
Breast Cancer Res Treat
. 2018 Jul;
172(1):167-177.
PMID: 30030708
Purpose: To examine factors associated with non-adherence during 5 years of endocrine treatment, including the possible influence of comorbidity burden and specific medical conditions. Methods: From all women diagnosed with...
4.
Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P
Ann Oncol
. 2018 Jul;
29(9):2020-2021.
PMID: 29992285
No abstract available.
5.
Arthur R, Williams R, Garmo H, Holmberg L, Stattin P, Malmstrom H, et al.
Int J Cancer
. 2018 Jan;
142(11):2254-2262.
PMID: 29322512
Inflammation is a well-documented driver of cancer development and progression. However, little is known about its role in prostate carcinogenesis. Thus, we examined the association of C-reactive protein (CRP), haptoglobin,...
6.
Kumar S, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, et al.
Leukemia
. 2017 Dec;
32(4):986-995.
PMID: 29263438
Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM) particularly for upfront autologous hematopoietic cell transplant (AHCT) recipients. We hypothesized that new drug classes and...
7.
Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P
Ann Oncol
. 2017 Nov;
29(2):377-385.
PMID: 29161337
Background: Old age at prostate cancer diagnosis has been associated with poor prognosis in several studies. We aimed to investigate the association between age at diagnosis and prognosis, and if...
8.
Mahindra A, Hari P, Fraser R, Fei M, Huang J, Berdeja J, et al.
Bone Marrow Transplant
. 2017 Sep;
52(12):1616-1622.
PMID: 28920949
Autologous hematopoietic cell transplantation (AHCT) in multiple myeloma (MM) patients with renal insufficiency (RI) is controversial. Patients who underwent AHCT for MM between 2008 and 2013 were identified (N=1492) and...
9.
Rowley M, Garmo H, Van Hemelrijck M, Wulaningsih W, Grundmark B, Zethelius B, et al.
Stat Med
. 2017 Feb;
36(13):2100-2119.
PMID: 28233395
Survival data analysis becomes complex when the proportional hazards assumption is violated at population level or when crude hazard rates are no longer estimators of marginal ones. We develop a...
10.
Gauthier J, Holmberg L, Wu D, Bensinger W, Gopal A, Press O, et al.
Bone Marrow Transplant
. 2016 Oct;
51(12):1617-1619.
PMID: 27775693
No abstract available.